Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease marker.
A reliable and specific immunoassay has been developed to detect and measure AD7C-NTP, a biochemical marker for Alzheimer's disease, in urine. The urine samples are first processed by centrifugation and ultrafiltration to fractionate and concentrate AD7C-NTP. The urinaryAD7C-NTP has the same molecular weight asAD7C-NTP in brain and cerebrospinal fluid by size exclusion chromatography. It has also retained the binding properties to the monoclonal and polyclonal antibodies developed against recombinantly produced AD7C-NTP. This assay is an enzyme linked sandwich immunoassay (ELSIA) using 96 well microtiter plates. The plate surface is coated with a monoclonal antibody (N314) which has a high affinity and specificity for AD7C-NTP, capturing it effectively from the samples. The detection was achieved using a polyclonal antibody (ADRI). The utility of the assay has been demonstrated using urine specimens from Alzheimer's disease (AD) patients and non-Alzheimer's controls. UrinaryAD7C-NTP in the AD group (2.5 ng/mL, n=66) was significantly higher than the non-AD group (0.8 ng/mL, n=134). Using 1.5 ng/mL as cut off, in this patient population, specificity and sensitivity of urinary AD7C-NTP were comparable to CSFAD7C-NTP.
Nymox Corporation, Rockville, Maryland 20895, USA.
H
H
Ghanbari
K
K
Ghanbari
I
I
Beheshti
M
M
Munzar
A
A
Vasauskas
P
P
Averback
D000544:Alzheimer Disease / Q000175:diagnosis* / Q000652:urine; D000911:Antibodies, Monoclonal; D015415:Biomarkers / Q000652:urine; D001921:Brain / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D006801:Humans; D009419:Nerve Tissue Proteins / Q000134:cerebrospinal fluid / Q000652:urine*
C109804:AD7c-NTP; D000911:Antibodies, Monoclonal; D015415:Biomarkers; D009419:Nerve Tissue Proteins